Biliary tract cancer

John A. Ehrenfried, Jean Nicolas Vauthey

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Recent advances in the molecular and cellular biology, diagnosis, and treatment of biliary tract cancer are reviewed. Several studies have delineated the molecular and cellular biology of cholangiocarcinoma and gallbladder carcinoma. Hepatocyte growth factor seems to be mitogenic to gallbladder carcinoma, and its inhibition may have a therapeutic role in this disease. Evidence against an adenoma-carcinoma pathway in gallbladder mucosa is presented. Helical computed tomography may improve staging accuracy in biliary tract disease and plays a definite role in diagnosis of and treatment planning in gallbladder polyps. Complete surgical resection continues to provide the best long-term prognosis, and surgical drainage is most beneficial in cholangiocarcinoma. Controversy continues about the effects of laparoscopic procedures and abdominal wall tumor recurrence.

Original languageEnglish (US)
Pages (from-to)430-435
Number of pages6
JournalCurrent opinion in gastroenterology
Volume15
Issue number5
DOIs
StatePublished - 1999

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Biliary tract cancer'. Together they form a unique fingerprint.

Cite this